Sunflower Health Plan and Centene Foundation Announce $200,000 Grant to GoodLife Innovations

CenteneJul 1 12:00

Centene (NYSE:CNC) Hasn't Managed To Accelerate Its Returns

Yahoo FinanceJun 29 20:00

Barclays Maintains Centene(CNC.US) With Buy Rating, Cuts Target Price to $90

Barclays analyst Andrew Mok CFA maintains $Centene(CNC.US)$ with a buy rating, and adjusts the target price from $104 to $90.According to TipRanks data, the analyst has a success rate of 46.1% and a t

Futu NewsJun 29 09:31 · Ratings

How Is Centene's Stock Performance Compared to Other Healthcare Stocks?

BarchartJun 27 22:06

Barclays Adjusts Price Target on Centene to $90 From $104, Maintains Overweight Rating

MT NewswiresJun 27 19:08

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Yahoo FinanceJun 26 21:00